MYC and breast cancer: The first links between SUMO and Myc were obtained in breast cancer model cell lines where overexpression of Myc was shown to be synthetic lethal with the loss of Uba2/Aos1 SUMO E1 and Ubc9 SUMO E2 activity [37].